BioWorld® - Medical Device Daily
27.11.2012 • Views
Share Embed Flag

BioWorld® - Medical Device Daily

BioWorld® - Medical Device Daily

BioWorld® - Medical Device Daily

SHOW MORE
SHOW LESS
ePAPER READ
DOWNLOAD ePAPER
medicaldevicedaily.com

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

START NOW

Digene Corp.<br />

BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information<br />

1201 Clopper Road<br />

Gaithersburg MD 20878, US<br />

Phone: (301) 944-7000; Fax: (240) 632-7121<br />

Toll-free phone: (800) DIGENE<br />

Web: www.digene.com; E-mail: inforeq@digene.com<br />

KEY PERSONNEL: Attila T. Lorincz; Sr. VP, R&D and CSO<br />

Joseph Slattery; CFO<br />

Belinda O. Patrick; Sr. VP, Manufacturing Operations<br />

Robert McG. Lilley; Sr. VP, Global Sales and Marketing<br />

Donna Marie Seyfried; VP, Business Development<br />

EMPLOYEES: 401 employees<br />

HISTORY: Founded in 1985<br />

Acquired the molecular diagnostics division of Life Technologies Inc. (12/90)<br />

Name changed from Digene Diagnostics Inc. (1996)<br />

FACILITIES: 110,000 sq. ft. R&D and manufacturing facility<br />

STOCK-FINANCIAL HISTORY: NASDAQ--DIGE<br />

IPO--$35M (5/96)<br />

Public offering--2.25M shares of common stock at $10/share, $22.5M<br />

(10/97)<br />

Public offering--2M shares of common stock at $28/share, $56M (11/05)<br />

Revenue $152.888M (YE 06) compared to $115.142M (YE 05)<br />

Net income $8.439M (YE 06) compared to (YE 05)<br />

Earnings per share $0.39/share (YE 06) compared to <br />

(YE 05)<br />

Average shares outstanding 21.769M (YE 06) compared to 19.965M (YE<br />

05)<br />

Total assets $231.886M (YE 06) compared to $106.845M (YE 05)<br />

SUBSIDIARIES/DIVISIONS: Digene Europe - London, England<br />

BUSINESS STRATEGY: Develop DNA diagnostic and biomedical supply company through internal<br />

developments, strategic partnerships and acquisitions<br />

AGREEMENTS: Name Products Content of Agreement Date<br />

Asuragen Inc. Asuragen's cystic worldwide marketing 4/06<br />

fibrosis screening and distribution<br />

products<br />

agreement<br />

Cytyc Corp. Digene's DNA probe development 10/96<br />

tests and Cytyc's<br />

specimen collection<br />

and preparation<br />

technology<br />

agreement<br />

International<br />

five-year exclusive 2/97<br />

Murex<br />

agency agreement<br />

Technologies<br />

for distribution in<br />

Corp.<br />

Europe<br />

International Digene's tests for HIV distribution<br />

9/97<br />

Murex<br />

RNA, hepatitis B and agreement for<br />

Technologies cytomegalovirus Europe, the U.K.,<br />

Corp.<br />

Africa, the Middle<br />

East and Singapore<br />

(1993), extended<br />

International infectious disease worldwide<br />

4/98<br />

Murex<br />

DNA probe diagnostics development and<br />

Technologies<br />

distribution<br />

Corp.<br />

agreement,<br />

expanded to include<br />

STD products (6/94)<br />

Mitsubishi<br />

DNA diagnostic probes distribution<br />

10/98<br />

Petrochemical Co. for disease detection agreement for Japan<br />

Copyright ©2006 AHC Media ® 133

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!